Jeff Yass’s Inozyme Pharma INZY Stock Holding History

Jeff Yass’s Portfolio INZY Stock Details INZY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-33,000	Closed	-$132K	–	13125
2025 Q2	$132K	Buy	+33,000	New	+$81.7K	﹤0.01%	11601
2024 Q3	–	Sell	-16,100	Closed	-$71.8K	–	12476
2024 Q2	$71.8K	Buy	+16,100	New	+$78.1K	﹤0.01%	11231
2024 Q1	–	Sell	-19,200	Closed	-$81.8K	–	12715
2023 Q4	$81.8K	Sell	19,200 -153,400	-89%	-$545K	﹤0.01%	11461
2023 Q3	$725K	Buy	172,600 +158,000	+1,082%	+$804K	﹤0.01%	7368
2023 Q2	$81.3K	Sell	14,600 -4,900	-25%	-$29K	﹤0.01%	11095
2023 Q1	$112K	Buy	+19,500	New	+$51.5K	﹤0.01%	11198

Jeff Yass's INZY Position: Q3 2025 in Review

Jeff Yass sold out of Inozyme Pharma (INZY) in Q3 2025, closing a stake of 224,981 shares — an estimated $900K sold.

Jeff Yass first reported a position in INZY in Q3 2020 and held it in 9 quarters. The position peaked at $900K in Q2 2025. 0 funds tracked by Wall St. Rank hold INZY as of Q3 2025.

Jeff Yass reported no remaining Inozyme Pharma position as of Q3 2025 after selling out during the quarter.
Jeff Yass sold 224,981 Inozyme Pharma shares in Q3 2025, an estimated $900K.
Jeff Yass first reported a position in Inozyme Pharma in Q3 2020 and held it in 9 quarters.
Jeff Yass's Inozyme Pharma position peaked at $900K in Q2 2025.
0 funds tracked by Wall St. Rank held Inozyme Pharma as of Q3 2025.

Based on Susquehanna International Group's 13F filing for Q3 2025, filed 14 Nov 2025.